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Background and purpose   It has been suggested that a higher 
procedure volume is associated with less complications after hip 
arthroplasty. In order to investigate the incidence of serious nega-
tive outcomes and a possible association with procedure volume, 
we performed a retrospective nationwide cohort study on total 
hip replacements in all Dutch hospitals. 
Methods   All total hip replacements (n = 50,080) that were 
identified as primary intervention in all general and university 
medical centers between January 1, 2002 and October 1, 2004 
were included. Primary endpoints of follow-up were mortality 
and  complications  during  admission,  and  re-admission  within 
3 months due to complications. Variables that were assessed as 
potential  risk  factor  were  age,  sex,  duration  of  (preoperative) 
admission, specific diagnosis, acute/non-planned admission, co-
morbidity, and hospital procedure volume.
Results   Age, sex, and comorbidity were associated with com-
plications  and  mortality.  Additionally,  acute  admission  was  a 
risk factor for mortality but not for complications. There was no 
linear trend indicating that decreasing volume led to an increas-
ing number of complications, and no statistically sginificant effect 
for mortality was found.
Interpretation   After adjustment for several risk factors, we 
found that the hospitals performing most hip procedures every 
year had fewer complications during index admission, but that 
they did not have a lower mortality than groups performing fewer 
procedures. The lack of a linear trend may be explained by the 
fact that almost all Dutch hospitals perform a high number of hip 
arthroplasties each year. 

Approximately 20,000 total hip replacements are performed 
in Dutch general and university hospitals each year (Prismant 
2009). It is expected that this number will increase to more 
than 30,000 in 2030 and to more than 50,000 in the longer 
term (Otten et al. 2010). Mortality, significant blood loss, post-
operative infections, deep venous thrombosis (DVT), disloca-
tions of the prosthesis, and instability are the most common 
early complications. Risk factors for complications are the 
type of intervention (hemiarthroplasty, total hip replacement, 
revision, trauma surgery), age, sex, and other patient-related 
factors such as obesity (Lübbeke et al. 2007). Furthermore, 
several studies have shown an association between compli-
cations on the one hand and experience of the surgeon and 
the hospital on the other, expressed as annual number of hip 
arthroplasties (Kreder et al. 1997, Katz et al. 2001, Solomon 
et al. 2002, Losina et al. 2004, Battaglia et al. 2006, Doro et al. 
2006, Judge et al. 2006, Cram et al. 2007, Shervin et al. 2007, 
Manley et al. 2008, Bozic et al. 2010, SooHoo et al. 2010).
Most studies have been performed in the United States, and 
due to differences in healthcare systems, it is not clear whether 
these results can be generalized to other countries. The aim of 
our retrospective nationwide cohort study was to gain insight 
into the incidence and risk of several serious complications of 
hip arthroplasty, both during the index hospitalization period 
and within the first 3 months after surgery. In addition, we 
assessed the importance of risk factors for complications such 
as the experience of the hospital, expressed as the number of 
interventions  performed  annually  and  corrected  for  several 
patient-related  factors  such  as  age,  sex,  co-morbidity,  and 
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Patients and methods 
Setting
Data were retrieved from a nationwide computer database 
of  hospital  discharge  records,  with  complete  coverage  of 
all admissions in all general and university hospitals in the 
Netherlands  (which  has  16  million  inhabitants).  None  of 
these hospitals is private. The university hospitals are owned 
by the government and the general hospitals are independent 
foundations, financed by public money. Private clinics did not 
perform THAs. The database includes (among other infor-
mation) basic patient characteristics, date of admission and 
discharge, the main intervention (coded), the medical spe-
cialist (coded), and the main and secondary diagnoses at dis-
charge, based on the ICD-9-CM coding system (ICD-9-CM, 
1978). Characteristics of hospitalizations are registered by 
treating medical specialists or residents and coded by pro-
fessional code clerks on the basis of hospital discharge let-
ters. For every admission, one main diagnosis or diagnosis 
at discharge (mandatory) and up to 9 secondary diagnoses 
(optional) are registered. The coding is independent of reim-
bursement of the hospital or specialist. In addition, hospitals 
remain anonymous with the use of unique codes, instead of 
name and address data. All diagnoses are submitted in the 
same format, mostly electronically.
Cohort and outcome definition
All patients admitted for a first total hip arthroplasty between 
January 1, 2002 and October 1, 2004 were included in this 
nationwide  cohort  study  (n  =  50,080).  This  was  the  most 
recent dataset available, with sufficient power due to the large 
number of records. Each cohort member was followed only 
once from the day of the hip arthroplasty (index hospitaliza-
tion) until the earliest of one of the following events: death 
during index admission, a complication, or end of the follow-
up time of 3 months, whichever came first. Patients with an 
ICD-9 code indicating certain non-fatal complications related 
to the implant, such as mechanical loosening, dislocation, or 
infection of the implant during the index hospitalization were 
excluded since these complications may have been related to 
an earlier intervention and not to the index intervention that 
was performed during the study period. All interventions with 
codes  indicating  removal  or  revision  of  hip  implants  were 
excluded from the database, except when such removals or 
revisions occurred within 3 months after the index operation, 
as they may have indicated a complication.
In the total population, we identified 82,582 admissions 
for hemiarthroplasty and total hip arthroplasty in the period 
2002–2004. After exclusion of patients who were admitted 
in 2001 but discharged in 2002, admissions later than Sep-
tember 30, 2004 to ensure at least 3 months of follow-up, 
patients  discharged  with  codes  indicating  a  complication 
from an earlier procedure, and patients with certain types of 
malignancies,  fractures,  and  hemiarthroplasties,  the  study 
cohort consisted of 50,080 admissions for primary total hip 
arthroplasty. 
In the Netherlands, most patients with a hip fracture have a 
hemiarthroplasty procedure, while patients with osteoarthrosis 
receive a total hip replacement. Patients with a fracture are 
clinically different from patients with osteoarthrosis. Thus, we 
excluded patients with fractures from the study cohort. Addi-
tionally, patients with osteoarthrosis or another diagnosis that 
was not fracture were excluded if they had hemiarthroplasty 
(see Figure). 
We  assessed  the  proportion  of  deaths  and  complications 
that occurred during the index hospitalization and the propor-
tion of re-admissions as a result of a selected set of potential 
complications within 3 months of the index hospitalization. 
We searched the original database records over the period of 
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Figure 1. Schematic representation of exclusion of patients from study population
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April 1, 2002 to January 1, 2005 for admitted patients with 
the same date of birth, sex, postal code of their home address, 
and hospital identification code, as we found that almost all 
patients  were  re-admitted  to  the  same  hospital.  Complica-
tions were identified based on the ICD-9 codes of the main 
discharge diagnoses and on literature (Kreder et al. 1997, Katz 
et al. 2001). As complications during index hospitalization we 
considered  ICD-9  codes  describing  pulmonary  embolism, 
specific complications affecting specified body systems such 
as  cardiac,  vascular,  respiratory,  or  urinary  complications, 
complications of procedures, and complications of medical 
care. Reasons for re-admission that were considered as com-
plications were: several types of infection, dislocation, vascu-
lar complications, and complications due to the procedure or 
implant. For this, we used a specific list, which was described 
earlier by Kreder et al. (1997) and Katz et al. (2001). In addi-
tion, removal or revision of hip arthroplasty within 3 months 
of the index operation was also considered to be an indication 
of a complication and was therefore included as an endpoint.
Hospital volume
During the study period, the Netherlands had 88 general hos-
pitals and 8 university medical centers. 2 of the 96 hospitals 
only  performed  hemiarthroplasties;  therefore,  94  hospitals 
remained in the study. Some hospitals have more than one 
location, but for the purpose of our research they were consid-
ered as one organization. The Netherlands is a densely popu-
lated country with a relatively old population. The average 
number of hip procedures per hospital may therefore be higher 
than in other countries. Only 13 hospitals performed less than 
100 total hip arthroplasties annually during the study period. 
When hemiarthroplasties and fractures were also considered, 
this number was even lower. 
We divided the hospitals into 5 volume groups based on the 
mean number of total hip arthroplasties performed per year. 
The lowest volume group performed less than 100 procedures 
a year and the highest volume group performed more than 400 
procedures a year. The number of patients in each of these 
groups (see Tables 3 and 4) is the number of patients from the 
total cohort who were in that group during the study period of 
2.75 years.
Our data did not allow us to distinguish between individual 
surgeons. Orthopedic surgeons performed almost all of the 
total hip replacements (99.9%). 
Covariables
As covariables, the following variables were considered for 
inclusion  in  the  models:  age  and  sex,  surgical  procedure 
volume per hospital, and co-morbidity in the year prior to the 
intervention that was severe enough for hospitalization and 
diagnosis. In order to assess co-morbidity a year before sur-
gery, we searched the original database records over the period 
January 1, 2001 to January 1, 2005 for admitted patients who 
had the same date of birth, sex, and postal code. We classified 
co-morbidity according to the Charlson co-morbidity index 
(Charlson et al. 1987) as adapted by Deyo et al. for ICD-9 
databases (Deyo et al. 1992). Furthermore, we considered the 
diagnosis, whether admission was acute and unplanned, dura-
tion of admission before surgery and total duration of admis-
sion. 
Validation
We performed validation of procedures, complications, and 
mortality in a sample of our study material by linking it to the 
Rotterdam Study, a prospective population-based cohort study 
of chronic diseases in the elderly who live in the Ommoord 
district of the city of Rotterdam (Hofman et al. 1991, 2007, 
2009).
By matching according to date of birth, sex, and postal code 
of the home address, we identified 68 patients from the study 
cohort in the Rotterdam Study. These 68 patients had been 
admitted to 3 hospitals in Rotterdam and surrounding area. 
For 40 patients, the original file including the original dis-
charge letter was available for review. For 17 other patients, 
information from their general practitioner could be accessed 
digitally, and no information was available for the other 11 
patients.
Of all the procedures, diagnoses, and complications, 91% 
(CI: 84–99), 90% (CI: 82–97), and 80% (CI: 45–115), respec-
tively, were confirmed. The remainder was missing and could 
not be judged. However, no procedures, diagnoses, or compli-
cations were false-positive.
Analysis
Descriptive  analyses  were  conducted  using  SPSS  software 
version  15.0.  Statistical  comparison  of  means  and  propor-
tions  consisted  of  independent  samples  t-tests  (Student’s), 
and chi-square tests. Because the precise delay between hip 
arthroplasty and complications during the index hospitaliza-
tion was not available in the database, we used logistic regres-
sion analysis with the first occurrence of a complication as 
endpoint instead of a Cox proportional hazards model. Covari-
ables that were considered as risk factors in the literature were 
tested in a univariable logistic regression analysis in order to 
obtain crude odds ratios. The final multivariable models were 
fitted by backward elimination regression based on the maxi-
mum likelihood ratio (Sun et al. 1996). The effect of a variable 
on the risk of complication was expressed as an odds ratio 
with a 95% confidence interval (CI).
Results 
Approximately half of the patients were older than 70 years, 
with a mean age of 69 years (SD 11), and about 70% were 
women. The median duration of admission was 9 days, with a 
median preoperative stay of 1 day. Most patients were admit-
ted with a diagnosis of osteoarthritis (97%) and 7% had one 548  Acta Orthopaedica 2011; 82 (5): 545–552
or more co-morbidities. About 1% (n = 504) of the admissions 
were not planned. Most of these patients (n = 408, 81%) had 
osteoarthritis as the main diagnosis, 9.5% (n = 48) had other 
bone defects such as aseptic bone necrosis and malunion/non-
union of fracture, and another 9.5% (n = 48) had a variety of 
other diagnoses; 11 of the patients of this group had osteoar-
thritis as secondary diagnosis. The reason for these admissions 
being acute/unplanned was not mentioned. The mortality rate 
during the index admission was 0.2% (n = 114), and 2.2% 
appeared to be associated with mortality. Furthermore, a com-
plication during the index admission was a risk factor for mor-
tality, with an adjusted odds ratio of 13 (CI: 8–21). Hospital 
groups performing fewer procedures appeared to be associ-
ated with a lower risk of mortality than the hospital group that 
performed most interventions. However, the odds ratios did 
not reach statistical significance.
Table 4 shows the univariable and multivariable analysis of 
several risk factors with complications during the index admis-
Table 1. Baseline characteristics of the study cohort (n = 50,080)
  All admissions  Males  Females
  n = 50,080  n = 14,966,  n = 35,114,
Characteristics: Primary total hip replacement    30%  70%
     
Mean age, years (SD)  68.7 (10.6)  65.9 (11.0)  70.0 (10.1)
   Median age, years (range)  70 (15–99)  67 (15–99)  71 (15–99)
Median duration of admission, days (range)    9 (1–137)    8 (1–137)    9 (1–133)
Median duration of preoperative admission, 
  days (range)    1 (0–80)    1 (0–80)    1 (0–76)
Acute, unplanned admission, n (%)       504 (1.0)       132 (0.9)  372 (1.1)
Any co-morbidity, n (%)    3,423 (6.8)    1,164 (7.8)  2,259 (6.4)
Specialist:     
  Orthopedic surgeon, n (%)  50,038 (99.9)  14,956 (99.9)  35,082 (99.9)
  General surgeon, n (%)         34 (0.1)           9 (0.1)         25 (0.1)
  Other surgeon, n (%)           8 (< 0.1)           1 (< 0.1)           7 (< 0.1)
Died during admission (all causes), n (%)       114 (0.2)         42 (0.3)         72 (0.2)
Complication during admission, n (%)    1,115 (2.2)       350 (2.3)       765 (2.2)
Re-admitted with a complication at least 
  once within 3 months    1,765 (3.5)       595 (4.0)     1,170 (3.3)
Any unfavorable outcome a    2,880 (5.8)       947 (6.3)     1,933 (5.5)
Diagnosis     
  Osteoarthritis, n (%)  48,313 (96.5)  14,260 (95.3)  34,053 (97.0)
  Aseptic bone necrosis, n (%)       937 (1.9)       419 (2.8)       518 (1.5)
  Congenital deformity of hip, n (%)       141 (0.3)         37 (0.2)       104 (0.3)
  Rheumatoid arthritis, n (%)       121 (0.2)         31 (0.2)         90 (0.3)
  Other, n (%)       568 (1.1)       219 (1.5)       349 (1.0)
     
a Complication during index admission and/or re-admission due to complication up to 3 times 
within 3 months of surgery.
Table 2. Characteristics of first 3 re-admissions within 3 months of surgery
  First   Second  Third
  n = 4,364  n = 759  n = 167   
  n  % (95% CI)  n  % (95% CI)  n  % (95% CI)
           
Second total hip replacement  423       9.7 (8.8–10.6)  25       3.3 (2.0–4.6)  3       1.8 (–0.2 to 3.8)
Complication during index admission  156       3.6 (3.0–4.1)  34       4.5 (3.0–6.0)  6       3.6 (0.8–6.4)
Re-admission was acute/unplanned  2,534     58.1 (56.6–59.5)  397     52.3 (48.8–55.9)  72     43.1 (35.6–50.6)
Mortality during re-admission  83       1.9 (1.5–2.3)  9       1.2 (0.4–2.0)  5       3.0 (0.4–5.6)
Readmission was due to complication  1,765     40.4 (39.0–41.9)  322     42.4 (38.9–46.0)  70     41.9 (34.4–49.4)
Complications specified:  1,765   100  322   100  70   100
   Mechanical complication of device  892     50.5 (48.2–52.9)  212     65.8 (60.7–71.0)  43     61.4 (50.0–72.8)
   Infection  526     29.8 (27.7–31.9)  73     22.7 (18.1–27.2)  20     28.6 (18.0–39.2)
   Dislocation  47       2.7 (1.9–3.4)  10       3.1 (1.2–5.0)  0       0.0 (0.0–0.0)
   Pulmonary embolism  58       3.3 (2.5–4.1)  5       1.6 (0.2–2.9)  1       1.4 (–1.4 to 4.2)
   Deep vein thrombosis  61       3.5 (2.6–4.3)  4       1.2 (0.03–2.5)  1       1.4 (–1.4 to 4.2)
   Other  180     10.2 (8.8–11.6)  18       5.6 (3.1–8.1)  5       7.1 (1.1–13.2)
(n = 1,115) of the patients had one 
or  more  complications.  Including 
re-admissions during the 3 months 
after surgery, 5.8% (n = 2,880) of the 
patients had a complication—either 
during the index admission or after 
re-admission for that reason (Table 
1).
Almost  9%  (n  =  4,364)  of  the 
patients  were  re-admitted  at  least 
once  within  3  months  of  surgery. 
About  40%  (n  =  1,756)  were  re-
admitted with a complication of the 
procedure, most of which involved 
a  mechanical  complication  of  the 
device (51%, n = 892) or an infec-
tion (30%, n = 526). The second and 
third re-admissions within the same 
time frame showed a similar picture 
(Table 2). Of these 4,364 patients, 
about  10%  were  admitted  for  a 
second hip replacement. 
Table 3 shows the univariable and 
multivariable analyses of all risk fac-
tors associated with mortality during 
the index admission. Age, male sex, 
co-morbidity, and certain diagnoses Acta Orthopaedica 2011; 82 (5): 545–552 
sion and the first 3 re-admissions within 3 months of surgery. 
Age, male sex, co-morbidity, and diagnosis (aseptic bone 
necrosis and other) were statistically significantly associated 
with both endpoints. Hospital volume appeared to be asso-
ciated with complications during the index admission, as all 
lower-volume groups had higher odds ratios than the high-
volume group. However, it did not show the linear trend that 
would have been expected. For re-admissions due to compli-
cations, this association was not apparent.
Discussion
In this study we found that during the index admission for 
total hip replacement, the percentage of complications was 
2.2%. Almost 9% of the patients in the study cohort who were 
admitted between January 1, 2002 and October 1, 2004 for 
THA were re-admitted for any cause at least once within 3 
months of surgery. However, 40% of these re-admissions were 
due to a complication that could be related to the implantation. 
(2010) found a mortality rate of 0.7% and a complication 
rate of 3.8% within 90 days. It is possible that the mortal-
ity rate is higher and shows more differences between volume 
groups when mortality that occurs after discharge is taken into 
account.  Mortality within 3 months of surgery may still be 
related to the procedure, although the rate is rather low due 
to  modern  advances  in  surgery,  anesthesia,  and  rehabilita-
tion—and despite early discharges, operations on older and 
more fragile individuals, and earlier rehabilitation (Pulido et 
al. 2008, Aynardi et al. 2009). 
In  the  past  decade,  several  studies  have  been  performed 
on the incidence of complications following surgery and the 
effect of hospital and surgical procedure volume (Kreder et al. 
1997, Katz et al. 2001, Losina et al. 2004, Battaglia et al. 2006, 
Doro et al. 2006, Judge et al. 2006, Cram et al. 2007, Shervin 
et al. 2007, Manley et al. 2008, Bozic et al. 2010). Many of 
these studies had a follow-up time of 3 months after surgery, 
since it appeared that the largest proportion of complications 
manifests itself within that time period, an extensive propor-
tion of which occurred within a few days of surgery (Kreder 
Table 3. Adjusted associations of all risk factors with mortality per hospital group  
  Early mortality during index admission
  Crude OR (95% CI)  Adjusted OR (95% CI)
Hospital volume as no. of total
hip procedures a per year
  > 400 (nh = 7 / np = 8,813) b  ref  ref
  300–400 (nh = 12 / np = 10,260)    0.94 (0.52–1.7)     0.8 (0.44–1.5)
  200–300 (nh = 20 / np = 12,413)    1.2 (0.67–2.0)    1.1 (0.6–2)
  100–200 (nh = 42 / np = 16,196)    0.91 (0.53–1.6)    0.76 (0.44–1.3)
  < 100 (nh = 13 / np = 2,398)    0.18 (0.02–1.3)    0.17 (0.02–1.2)
Female sex    0.73 (0.5–1.1)    0.58 (0.39–0.86)
Age (quartiles of no. of patients)   
  ≤ 65  ref  ref
  66–72    1.8 (0.81–4.0)    2 (0.88–4.4)
  73–79    5.6 (2.8–11)    5.8 (2.9–12)
  ≥ 80  11 (5.5–22)  11 (5.4–22)
Co–morbidity c   
  Score 0  ref  ref
  Score 1    3.9 (2.3–6.4)    2.7 (1.6–4.6)
  Score 2    6.8 (3.1–15)    4.2 (1.9–9.3)
  Score 3  12 (4.7–29)    6 (2.3–16)
Diagnosis   
  Osteoarthritis  ref  ref
  Aseptic bone necrosis    3.3 (1.5–7.6)    3.2 (1.4–7.6)
  Congenital deformity of hip    –    –
  Rheumatoid arthritis    4.3 (0.59–31)    2.3 (0.29–18)
  Other  12 (6.7–22)    7.9 (4.1–15)
Acute, unplanned admission    6.5 (3–14)    3 (1.2–7.2)
Duration of index admission    1 (1–1.1) d    1 (0.95–1) e
Duration of preoperative admisison    1.1 (1–1.1) f    – g
Complication during index admission  18 (12–27)  13 (8.4–21)
a Fractures and hemiarthroplasties excluded.
b nh = no. of hospitals / np = no. of patients in group.
c Charlson co-morbidity index, adapted by Deyo et al. for ICD–9 databases
d Results with 2 decimals: 1.04 (1.02–1.05).
e Results with 3 decimals: 0.972 (0.947–0.999).
f  Results with 2 decimals: 1.06 (1.03–1.10).
g Not in final multivariable model.
Altogether, approximately 6% of the cohort 
of patients studied experienced a complica-
tion during index admission and/or within 3 
months after the implantation. Acute admis-
sion appeared to be a risk factor for compli-
cations during index admission in the unad-
justed analysis, but it was not selected as a 
risk factor in the final model. This may have 
been caused by adjustment for co-morbidity 
and diagnosis, variables that may confound 
the effect of acute admission.
The mortality during admission was 0.2% 
for patients with a total hip replacement. A 
complication  during  index  hospitalization 
was strongly associated with mortality. How-
ever, as might be expected, mortality could 
not  be  entirely  related  to  the  intervention, 
since  age,  co-morbidity,  and  acute  admis-
sion (i.e. trauma) were also associated with it. 
The high-volume group had a higher risk of 
mortality than 3 of the lower-volume groups. 
This may be explained by the fact that com-
plicated  total  hip  replacements  are  usually 
referred to high-volume centers. However, we 
did not find that higher hospital volume was 
associated with lower mortality, as found in 
previous studies (Shervin et al. 2007, Bozic 
et al. 2010). Furthermore, we must note here 
that the data came from the Dutch National 
Medical Registration, which records all hos-
pital admissions until discharge. Thus, only 
mortality  during  admission  is  registered  in 
this database, and we were unable to moni-
tor mortality after discharge. SooHoo et al. 550  Acta Orthopaedica 2011; 82 (5): 545–552
et al. 1997, Katz et al. 2001, Philips et al. 2003, Parvizi et al. 
2007). Primary endpoints were mortality, infection, disloca-
tion and/or instability, deep vein thrombosis, and pulmonary 
embolism. In our study, we investigated the occurrence of any 
complication, including the above-mentioned outcomes, and 
infection, dislocation, deep vein thrombosis, and pulmonary 
embolism separately. 
Although hospital groups performing a lower number of 
THRs  were  more  strongly  associated  with  complications 
during the index admission than the highest-volume group, 
our study did not show a trend towards a lower proportion of 
complications when the number of interventions per hospi-
tal increased. Furthermore, there was no association between 
volume groups and re-admissions within 3 months. As the 
average number of hip arthroplasties per hospital was high 
in our study, this may have removed the potential difference 
between high-volume and low-volume hospitals. However, as 
in another study that did not find an effect of hospital volume 
on outcome (Zahn et al. 2007), and according to privacy legis-
lation, our administrative data did not allow us to identify the 
surgeons who performed the intervention. Several other stud-
ies showed that a higher volume of hip arthroplasties resulted 
in a lower incidence of complications, and suggested that pro-
cedure volume per surgeon is the most important determinant 
(Lavernia and Guzman 1995, Losina et al. 2004, Battaglia et 
al. 2006, Shervin et al. 2007, Manley et al. 2008). This was 
questioned in other studies, where the authors concluded that 
hospital volume is an important factor (Doro et al. 2006). It 
was also found that in patients who were operated by higher-
volume surgeons, higher hospital volume was independently 
Table 4. Crude and adjusted associations of all risk factors with complications during index admission and re–admission
  Complication during index admission  Re-admission due to complication 
  Crude OR (95% CI)  Adjusted OR (95% CI)  Crude OR (95% CI)  Adjusted OR (95% CI)
Hospital volume as no. of total
hip procedures a per year
  > 400 (nh = 7 / np = 8,813) b  ref  ref  ref  ref
  300–400 (nh = 12 / np = 10,260)  2.2 (1.7–2.8)   2.2 (1.7–2.7)  1.3 (1.1–1.5)  1.3 (1.1–1.5)
  200–300 (nh = 20 / np = 12,413)  2 (1.6–2.5)  1.9 (1.5–2.4)  1 (0.89–1.2) c  1 (0.88–1.2) d
  100–200 (nh = 42 / np = 16,196)  2 (1.6–2.5)  1.8 (1.5–2.3)  0.96 (0.84–1.1)  0.94 (0.82–1.1)
  < 100 (nh = 13 / np = 2,398)  2.3 (1.7–3.2)  1.9 (1.4–2.6)  1.1 (0.9–1.4)  1.1 (0.87–1.4)
Female sex  0.93 (0.82–1.1)  0.78 (0.68–0.9)  0.83 (0.75–0.92)  0.79 (0.71–0.87)
Age (quartiles of no. of patients)     
  ≤ 65  ref  ref  ref  ref
  66–72  1.3 (1.1–1.6)  1.2 (1–1.5) e  1.1 (0.93–1.2)  1.1 (0.98–1.3)
  73–79  2 (1.7–2.4)  1.5 (1.3–1.8)  1.5 (1.3–1.7)  1.6 (1.4–1.8)
  ≥ 80  2.6 (2.2–3.2)  1.5 (1.3–1.9)  1.7 (1.5–2)  1.9 (1.6–2.2)
Co–morbidity f       
  Score 0  ref  ref  ref  ref
  Score 1  2.1 (1.7–2.5)  1.7 (1.3–2.1)  1.5 (1.3–1.8)  1.4 (1.2–1.7)
  Score 2  2.5 (1.7–3.7)  1.8 (1.2–2.7)  1.7 (1.2–2.4)  1.5 (1.1–2.2)
  Score 3  3.1 (1.9–5.3)  1.9 (1–3.4) g  2 (1.2–3.3)  1.8 (1.1–2)
Diagnosis       
  Osteoarthritis  ref  ref  ref  ref
  Aseptic bone necrosis  2.1 (1.5–2.9)  1.8 (1.3–2.6)  1.8 (1.4–2.3)  1.8 (1.4–2.4)
  Congenital deformity of hip  –  –  0.19 (0.03–1.4)  0.22 (0.03–1.6)
  Rheumatoid arthritis  1.2 (0.37–3.7)  0.6 (0.16–2.2)  3 (1.6–5.4)  2.6 (1.4–4.8)
  Other  3.9 (2.8–5.3)  2.5 (1.7–3.5)  1.8 (1.2–2.5)  1.8 (1.2–2.5)
Acute, unplanned admission at
  index admission  1.8 (1.2–2.9)  – h  0.81 (0.49–1.4)  – h
Duration of index admission  1.1 (1.1–1.1) i  1.1 (1.1–1.1) j  1 (1–1) k  1 (0.98–1) l
Duration of preoperative admission  1 (1–1.1) m  0.87 (0.84–0.91)  0.99 (0.96–1)  – h
Complication during index admission  NA  NA  2 (1.6–2.5)  1.9 (1.5–2.5)
a  Fractures and hemiarthroplasties excluded.
b nh = no. of hospitals / n  = no. of patients in that group.
c  Results with 2 decimals: 1.04 (0.89–1.20).
d Results with 2 decimals: 1.02 (0.88–1.19).
e  Results with 2 decimals: 1.22 (1.01–1.46).
f  Charlson co-morbidity index, adapted by Deyo et al. for ICD–9 databases.
g Results with 2 decimals: 1.89 (1.04–3.41).
h Not in final multivariable model.
i  Results with 2 decimals: 1.10 (1.09–1.10).
j  Results with 3 decimals: 1.103 (1.095–1.110).
k  Results with 3 decimals: 1.004 (0.996–1.012).
l  Results with 3 decimals: 0.986 (0.977–0.995).
m  Results with 2 decimals: 1.04 (1.02–1.06).Acta Orthopaedica 2011; 82 (5): 545–552 
associated with lower early failure rates (Losina et al. 2004), 
but specialization of the hospital may also play a role (Cram et 
al. 2007). Furthermore, it has been suggested that the volume 
effect reaches a plateau and does not improve further regard-
less of increasing volume (Sharkey et al. 2004). Thus, hospital 
volume may still be an appropriate indicator of quality (Mer-
edith and Katz 2007). 
Finally, there may have been residual confounding caused 
by factors that could not be adjusted for in our analysis, such 
as type of prosthesis used, facilities in the operating room, and 
so on.
As far as we know, our study is the first nationwide study in 
which all primary total hip replacements have been included, 
and involves a high average number of hip procedures per 
hospital in a densely populated country. Also, validation of a 
sample showed that the quality of the registry is good. Further-
more, it is unlikely that there was selection bias, since Dutch 
inhabitants in need of hip arthroplasty are generally admitted 
to a Dutch hospital. Information bias due to knowledge of the 
research question was also unlikely, as the admissions were 
registered prospectively. However, false-negative misclassifi-
cation of cases could be an issue because we only had access 
to  data  about  mortality  during  hospitalization. Although  a 
median length of stay of 9 days is rather long for this type 
of procedure, it is still likely that some mortality related to 
the procedure occurred after discharge. Additionally, although 
trained  code  clerks  register  hospital  admissions,  mistakes 
in coding and deviations between employees and hospitals 
cannot  be  excluded.  However,  given  the  high  concordance 
between registered determinants and complications and medi-
cal  records  in  our  validation  sample,  we  think  that  this  is 
unlikely.
At least one additional diagnosis was mentioned in only 
25% of the admissions. Possible complications may not have 
been registered because such registration is optional and only 
registration of the main diagnosis is mandatory. This may have 
led to underestimation of the number of complications.
In conclusion, in contrast with results from USA hospitals, 
volume  does  not  fully  explain  the  differences  in  mortality 
and complications between hospitals in the Netherlands. This 
might be explained in part by the fact that the average number 
of hip arthroplasties per hospital is high. This might mean that 
under such circumstances, other determinants become more 
important in explaining differences—such as volume per sur-
geon or technical considerations such as type of prosthesis, 
surgical technique, use of cement, conditions in the operating 
rooms, or patient related factors. Other options that may be 
interesting for further investigation are (1) the degree of ortho-
pedic specialization of hospitals, as an association between 
this parameter and favorable outcome has been shown in a 
recent study (Hagen et al. 2010), and (2) the importance of 
standardization of the process, which was found to be strongly 
associated with better patient outcomes and more efficient use 
of resources in another study (Bozic et al. 2010).
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